Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Achillion Pharmaceuticals Inc (NASDAQ:ACHN)

3.39
BATS BZX Real-Time Price
As of 1:56pm ET
 -0.04 / -1.17%
Today’s Change
2.95
Today|||52-Week Range
5.66
-17.92%
Year-to-Date

Today’s Trading

Previous close3.43
Today’s open3.51
Day’s range3.39 - 3.54
Volume43,941
Average volume (3 months)1,916,337
Market cap$472.9M
Dividend yield--
Data as of 1:56pm ET, 11/22/2017

Growth & Valuation

Earnings growth (last year)-1,025.00%
Earnings growth (this year)-40.00%
Earnings growth (next 5 years)+5.23%
Revenue growth (last year)-77.31%
P/E ratioNM
Price/Sales37.63
Price/Book1.17

Competitors

 Today’s
change
Today’s
% change
ITCIIntra-Cellular Thera...+0.08+0.51%
SGYPSynergy Pharmaceutic...-0.01-0.52%
INSYINSYS Therapeutics I...+0.01+0.19%
MGNXMacroGenics Inc+0.27+1.35%
Data as of 1:59pm ET, 11/22/2017

Financials

Next reporting dateMarch 8, 2018
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$15.0M
Annual profit (last year)-$61.7M
Net profit margin-411.37%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Milind S. Deshpande
Chief Operating Officer &
Executive Vice President
Joseph Truitt
Corporate headquarters
New Haven, Connecticut

Forecasts